HYDROCHLOROTHIAZIDE

Post-LOE

hydrochlorothiazide

ANDAORALTABLET
Approved
Mar 2007
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. Hydrochlorothiazide does not usually affect normal blood pressure. Hydrochlorothiazide affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are…

Pharmacologic Class:

Thiazide Diuretic

Clinical Trials (5)

NCT06205407Phase 1Completed

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Started Dec 2023
42 enrolled
Healthy Participants
NCT03205137N/AWithdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Started Jun 2022
0
Hypertension
NCT03640221Phase 4Withdrawn

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.

Started Sep 2018
0
HypertensionDiabetes Mellitus, Type 2
NCT03387657Phase 1Completed

A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide

Started Jan 2018
16 enrolled
Type 2 Diabetes Mellitus
NCT03031496Phase 1Completed

Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions

Started Mar 2017
42 enrolled
Hypertension